Literature DB >> 16145534

Diagnosis and treatment of atypical and anaplastic meningiomas: a review.

Ashok Modha1, Philip H Gutin.   

Abstract

Atypical and anaplastic meningiomas are uncommon tumors with a poorer prognosis than benign meningiomas. We reviewed the current literature and attempted to integrate and summarize available information to determine a logical approach to these tumors. Both tumors are rare and are often integrated with benign meningiomas when treatments are evaluated. In addition, because there has not been one histopathological classification scheme for atypical and anaplastic meningiomas in the past, there are numerous inconsistencies in the literature. Malignant progression with accumulation of mutations in a benign meningioma can result in an atypical and/or anaplastic meningioma. Both tumors are difficult to manage and have high recurrence and poor survival rates. The extent of tumor resection and histological grade are the key determinants for recurrence. In addition, metastases are unusual, but they do occur. We also review the evidence available that has resulted in the current World Health Organization classification. Radiation therapy can be used as an adjunctive treatment after both total and subtotal resection. In addition, the role of stereotactic radiosurgery is increasing, along with a possible role for brachytherapy. There are no effective chemotherapeutic agents available. A treatment algorithm is suggested.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16145534     DOI: 10.1227/01.neu.0000170980.47582.a5

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  75 in total

1.  MGMT promoter methylation status in anaplastic meningiomas.

Authors:  Benjamin Brokinkel; Bernhard R Fischer; Susanne Peetz-Dienhart; Heinrich Ebel; Abolghassem Sepehrnia; Burckhard Rama; Friedrich K Albert; Walter Stummer; Werner Paulus; Martin Hasselblatt
Journal:  J Neurooncol       Date:  2010-05-07       Impact factor: 4.130

2.  Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy.

Authors:  Waseem Masalha; Dieter Henrik Heiland; Pamela Franco; Daniel Delev; Jan Gerrit Haaker; Oliver Schnell; Christian Scheiwe; Juergen Grauvogel
Journal:  J Neurooncol       Date:  2017-10-28       Impact factor: 4.130

3.  Meningiomas: skull base versus non-skull base.

Authors:  Torstein R Meling; Michele Da Broi; David Scheie; Eirik Helseth
Journal:  Neurosurg Rev       Date:  2018-04-07       Impact factor: 3.042

4.  Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.

Authors:  Andrew D Norden; Jeffrey J Raizer; Lauren E Abrey; Kathleen R Lamborn; Andrew B Lassman; Susan M Chang; W K Alfred Yung; Mark R Gilbert; Howard A Fine; Minesh Mehta; Lisa M Deangelis; Timothy F Cloughesy; H Ian Robins; Kenneth Aldape; Janet Dancey; Michael D Prados; Frank Lieberman; Patrick Y Wen
Journal:  J Neurooncol       Date:  2009-06-28       Impact factor: 4.130

5.  WHO grade II and III meningiomas: a study of prognostic factors.

Authors:  Anne Durand; François Labrousse; Anne Jouvet; Luc Bauchet; Michel Kalamaridès; Philippe Menei; Robert Deruty; Jean Jacques Moreau; Michelle Fèvre-Montange; Jacques Guyotat
Journal:  J Neurooncol       Date:  2009-06-27       Impact factor: 4.130

6.  Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.

Authors:  Varun R Kshettry; Quinn T Ostrom; Carol Kruchko; Ossama Al-Mefty; Gene H Barnett; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2015-05-24       Impact factor: 12.300

Review 7.  Pediatric meningioma: current approaches and future direction.

Authors:  Rishi S Kotecha; Reimar C Junckerstorff; Sharon Lee; Catherine H Cole; Nicholas G Gottardo
Journal:  J Neurooncol       Date:  2011-01-04       Impact factor: 4.130

8.  Atypical and malignant meningioma: outcome and prognostic factors in 68 irradiated patients.

Authors:  Beatrice Detti; Silvia Scoccianti; Vanessa Di Cataldo; Eleonora Monteleone; Samantha Cipressi; Lorenzo Bordi; Gianni Pellicanò; Davide Gadda; Calogero Saieva; Daniela Greto; Guido Pecchioli; Annamaria Buccoliero; Marco Ceroti; Franco Ammannati; Giampaolo Biti
Journal:  J Neurooncol       Date:  2013-09-18       Impact factor: 4.130

9.  Diffusion-weighted MR imaging: diagnosing atypical or malignant meningiomas and detecting tumor dedifferentiation.

Authors:  V A Nagar; J R Ye; W H Ng; Y H Chan; F Hui; C K Lee; C C T Lim
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

10.  Differentiation between classic and atypical meningiomas with use of diffusion tensor imaging.

Authors:  C-H Toh; M Castillo; A M-C Wong; K-C Wei; H-F Wong; S-H Ng; Y-L Wan
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.